101 related articles for article (PubMed ID: 1885162)
1. Heterogeneity of monoclonal antibody distribution and radiation dose in tumors: a modeling analysis.
Fujimori K
Hokkaido Igaku Zasshi; 1991 May; 66(3):369-84. PubMed ID: 1885162
[TBL] [Abstract][Full Text] [Related]
2. Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution.
Fujimori K; Fisher DR; Weinstein JN
Cancer Res; 1991 Sep; 51(18):4821-7. PubMed ID: 1893374
[TBL] [Abstract][Full Text] [Related]
3. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
Fujimori K; Covell DG; Fletcher JE; Weinstein JN
J Nucl Med; 1990 Jul; 31(7):1191-8. PubMed ID: 2362198
[TBL] [Abstract][Full Text] [Related]
4. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors.
Fujimori K; Covell DG; Fletcher JE; Weinstein JN
Cancer Res; 1989 Oct; 49(20):5656-63. PubMed ID: 2790783
[TBL] [Abstract][Full Text] [Related]
5. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier".
van Osdol W; Fujimori K; Weinstein JN
Cancer Res; 1991 Sep; 51(18):4776-84. PubMed ID: 1893370
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional dosimetry for intralesional radionuclide therapy using mathematical modeling and multimodality imaging.
Flux GD; Webb S; Ott RJ; Chittenden SJ; Thomas R
J Nucl Med; 1997 Jul; 38(7):1059-66. PubMed ID: 9225791
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.
Jain RK; Baxter LT
Cancer Res; 1988 Dec; 48(24 Pt 1):7022-32. PubMed ID: 3191477
[TBL] [Abstract][Full Text] [Related]
9. Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: theoretical and experimental pharmacokinetics.
Sung C; van Osdol WW; Saga T; Neumann RD; Dedrick RL; Weinstein JN
Cancer Res; 1994 Apr; 54(8):2166-75. PubMed ID: 8174124
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
11. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
12. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis in radioimmunotherapy of micrometastases: a mathematical modeling and dosimetrical analysis.
Sgouros G
J Nucl Med; 1992 Dec; 33(12):2167-79. PubMed ID: 1460511
[TBL] [Abstract][Full Text] [Related]
14. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity.
Sparks RB; Crowe EA; Wong FC; Toohey RE; Siegel JA
J Nucl Med; 2002 Aug; 43(8):1110-4. PubMed ID: 12163638
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
[TBL] [Abstract][Full Text] [Related]
17. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
Goodwin DA; Meares CF; Watanabe N; McTigue M; Chaovapong W; Ransone CM; Renn O; Greiner DP; Kukis DL; Kronenberger SI
Cancer Res; 1994 Nov; 54(22):5937-46. PubMed ID: 7954426
[TBL] [Abstract][Full Text] [Related]
19. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
[TBL] [Abstract][Full Text] [Related]
20. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
